Clinical trials suggest GLP-1s may improve fertility in men with obesity
.jpg&w=3840&q=75)
Recent clinical research indicates that GLP-1 receptor agonists, commonly used for weight management, may have positive effects on male fertility. The findings suggest a potential new therapeutic application for these medications in patients with obesity.
Why it matters
As GLP-1 usage grows, understanding their secondary health impacts is crucial for medical practitioners and patients managing obesity-related health complications.
News Advocacy Awards Endocrine Topics Education & Training Practice Guidelines Journals Meetings & Events Store Hello, Please login Your Account & Tools Learning Claim credits Plan your learning Browse journals and articles View sessions recordings Membership Renew membership Submit Your Science! Find other members Career Get published Earn recognition Develop your career Promote your work Join Login 0 Items Menu Login Sign Up The Latest Our Community Open Submenu Special Interest Groups Career & Professional Development EndoCareers Community & Global Exchange Expanding Field of Endocrinology About Endocrine Society Find an Endocrinologist Advancing Research Open Submenu Scientific Statements Research Opportunities Stay Informed: Scientific Journals Research Fellowships & Programs Research Awards Improving Practice Open Submenu Clinical Practice Guidelines Education & Training Physician Payment: QPP and MACRA Membership Open Submenu Member Rates Renew Membership Member Resources EndoForum Get Involved Membership Toolkit Partnerships Open Submenu Corporate Liaison Board ENDO 2026 Satellite Symposia Guidelines.pdf Advertise With Us JOIN OR RENEW TODAY! News Advocacy Awards Endocrine Topics Education & Training Practice Guidelines Journals Meetings & Events Store JOIN OR RENEW TODAY! Close The Latest Our Community Open Submenu Special Interest Groups Career & Professional Development EndoCareers Community & Global Exchange Expanding Field of Endocrinology About Endocrine Society Find an Endocrinologist Advancing Research Open Submenu Scientific Statements Research Opportunities Stay Informed: Scientific Journals Research Fellowships & Programs Research Awards Improving Practice Open Submenu Clinical Practice Guidelines Education & Training Physician Payment: QPP and MACRA Membership Open Submenu Member Rates Renew Membership Member Resources EndoForum Get Involved Membership Toolkit Partnerships Open Submenu Corporate Liaison Board ENDO 2026 Satellite Symposia Guidelines.pdf Advertise With Us JOIN OR RENEW TODAY! Endocrine News News Room Clinical trials suggest GLP-1s may improve fertility in men with obesity SHARE email facebook twitter bluesky pinterest print Press Release Meetings & Events Clinical trials suggest GLP-1s may improve fertility in men with obesity Chicago, IL June 13, 2026 GLP 1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill. In fact, the research team found GLP-1s may improve testosterone levels and sperm quality in men with obesity related low testosterone, while also addressing the underlying effects of obesity.
The content is a professional summary of medical research findings from a specialized society.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in